Evidence map›Paper›PMID 41359026›Full record

ArticleCalcified tissue international2025

Correction to: Bone Mineral Density During Treatment with The Janus Kinase Inhibitor Baricitinib in Patients with Rheumatoid Arthritis: A Monocentric Observational Study.

Nils Schulz, Thomas Asendorf, Pascal van Wijnen, Tim Wilhelmi, Ulf Müller-Ladner, Uwe Lange, Philipp Klemm

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Calcified tissue international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Nils SchulzDepartment of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus Liebig University Giessen, Campus Kerckhoff, Benekestr. 2-8, 61231, Bad Nauheim, Germany. n.schulz@kerckhoff-klinik.de.ORCID http://orcid.org/0009-0000-0378-3766
Thomas AsendorfDepartment of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0003-1317-2138
Pascal van WijnenDepartment of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus Liebig University Giessen, Campus Kerckhoff, Benekestr. 2-8, 61231, Bad Nauheim, Germany.ORCID http://orcid.org/0009-0007-2629-1837
Tim WilhelmiDepartment of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus Liebig University Giessen, Campus Kerckhoff, Benekestr. 2-8, 61231, Bad Nauheim, Germany.ORCID http://orcid.org/0009-0008-2400-2840
Ulf Müller-LadnerDepartment of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus Liebig University Giessen, Campus Kerckhoff, Benekestr. 2-8, 61231, Bad Nauheim, Germany.ORCID http://orcid.org/0009-0000-8832-8112
Uwe LangeDepartment of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus Liebig University Giessen, Campus Kerckhoff, Benekestr. 2-8, 61231, Bad Nauheim, Germany.ORCID http://orcid.org/0000-0001-7904-0619
Philipp KlemmDepartment of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus Liebig University Giessen, Campus Kerckhoff, Benekestr. 2-8, 61231, Bad Nauheim, Germany.ORCID http://orcid.org/0000-0001-7911-4235

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41359026
PMCPMC12686034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.